Trial Profile
Impact of Escitalopram and Serotonin Transporter Polymorphisms on Emotion Processing and Regulation In Healthy Participants: A Randomised Controlled Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Depressive disorders; Generalised anxiety disorder; Obsessive-compulsive disorders; Panic disorder; Social phobia
- Focus Pharmacodynamics
- 08 Oct 2012 Status changed from not yet recruiting to completed as reported by Australian New Zealand Clinical Trials Registry.
- 16 Aug 2011 New trial record